EBITDA: Income before interest, taxes, depreciation and amortization.
Medicus Pharma Ltd (MDCX) had EBITDA of $-11.48M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-11.43M |
|
-- |
|
-- |
|
$11.48M |
|
$-11.48M |
|
$-0.21M |
|
$-11.68M |
|
$-11.68M |
|
$-11.68M |
|
$-11.68M |
|
$-11.68M |
|
$-11.68M |
|
$-11.48M |
|
|
EBITDA |
$-11.48M |
55.05M |
|
55.05M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$16.98M |
|
-- |
|
$10.13M |
|
$27.12M |
|
$10.84M |
|
$17.98M |
|
$18.00M |
|
$28.84M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
60.17M |
|
| Cash Flow Statement Financials | |
$-15.95M |
|
-- |
|
$32.35M |
|
$8.71M |
|
$25.19M |
|
$16.49M |
|
$2.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
1.11 |
|
-12.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
677.37% |
|
677.37% |
|
-43.09% |
|
-71.87% |
|
$-0.03 |
|
$-0.29 |
|
$-0.29 |
|